The Multiple Endocrine Neoplasia Type 2B Point Mutation Alters Long-term Regulation and Enhances the Transforming Capacity of the Epidermal Growth Factor Receptor

This publication has 25 references indexed in Scilit:

• Mechanism of Activation of the ret Proto-oncogene by Multiple Endocrine Neoplasia 2A Mutations
  Molecular and Cellular Biology, 1995
• Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B
  Science, 1995
• Single missense mutation in the tyrosine kinasecatalytic domain of the RET protooncogene is associated with multiple endocrineneoplasia type 2B.
  Proceedings of the National Academy of Sciences, 1994
• Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours
  Human Molecular Genetics, 1994
• A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma
  Nature, 1994
• Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
  Human Molecular Genetics, 1993
• Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
  Nature, 1993
• Crystal Structure of the Catalytic Subunit of Cyclic Adenosine Monophosphate-Dependent Protein Kinase
  Science, 1991
• The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
  Science, 1988
• Activation of a novel human transforming gene, ret, by DNA rearrangement
  Cell, 1985